Study to Evaluate the Safety and Efficacy of Lenacapavir (GS-6207) in Combination With an Optimized Background Regimen (OBR) in Heavily Treatment Experienced Participants Living With HIV-1 Infection With Multidrug Resistance
Clinical trial NCT04150068 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04150068
- Sponsor
- Gilead Sciences
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-21
- Primary completion
- 2020-10-05
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.